{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:10:50Z","timestamp":1777965050525,"version":"3.51.4"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Rosetrees Trust and LUPUS UK"},{"name":"National Institute for Health Research University College London Hospitals Biomedical Research Centre"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Patients with SLE have an increased risk of developing cardiovascular disease (CVD). Multiple studies have shown that these patients have increased numbers of carotid plaques and greater intima-media thickness (IMT) than healthy controls. Measures such as total plaque area (TPA) and plaque echogenicity may be more sensitive and more relevant to cardiovascular risk than presence of plaque and IMT alone. Our objective was to produce the first report of TPA and echogenicity in a population of patients with SLE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>One hundred patients with SLE and no history of clinical CVD were recruited. Clinical, serological and treatment variables were recorded and serum was tested for antibodies to apolipoprotein A-1 and high-density lipoprotein. Both carotid and both femoral artery bifurcations of each patient were scanned to determine IMT, TPA and echogenicity of plaques. Univariable and multivariable statistical analyses were carried out to define factors associated with each of these outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Thirty-six patients had carotid and\/or femoral plaque. Increasing age was associated with presence of plaque and increased IMT. Triglyceride levels were associated with presence of plaque. Mean (s.d.) TPA was 60.8 (41.6)\u2009mm2. Patients taking prednisolone had higher TPA. Most plaques were echolucent, but increased echogenicity was associated with prednisolone therapy and persistent disease activity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>TPA and plaque echogenicity in patients with SLE are associated with different factors than those associated with presence of plaque and IMT. Longitudinal studies may show whether these outcome measures add value in the management of cardiovascular risk in SLE.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa905","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T20:13:35Z","timestamp":1608063215000},"page":"4185-4198","source":"Crossref","is-referenced-by-count":14,"title":["Total plaque area and plaque echogenicity are novel measures of subclinical atherosclerosis in patients with systemic lupus erythematosus"],"prefix":"10.1093","volume":"60","author":[{"given":"Sara C","family":"Croca","sequence":"first","affiliation":[{"name":"Division of Medicine, Centre for Rheumatology Research, University College London"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Griffin","sequence":"additional","affiliation":[{"name":"Vascular Screening and Diagnostic Centre, London, UK"},{"name":"Vascular Screening and Diagnostic Centre, Nicosia, Cyprus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1517-4383","authenticated-orcid":false,"given":"Filipa","family":"Farinha","sequence":"additional","affiliation":[{"name":"Division of Medicine, Centre for Rheumatology Research, University College London"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9514-2455","authenticated-orcid":false,"given":"David A","family":"Isenberg","sequence":"additional","affiliation":[{"name":"Division of Medicine, Centre for Rheumatology Research, University College London"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Nicolaides","sequence":"additional","affiliation":[{"name":"Department of Surgery, Imperial College, London, UK"},{"name":"University of Nicosia Medical School, Cyprus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2346-4484","authenticated-orcid":false,"given":"Anisur","family":"Rahman","sequence":"additional","affiliation":[{"name":"Division of Medicine, Centre for Rheumatology Research, University College London"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"2021090119420736800_keaa905-B1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/annrheumdis-2014-206334","article-title":"The incidence and prevalence of systemic lupus erythematosus in the UK, 1999-2012","volume":"75","author":"Rees","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2021090119420736800_keaa905-B2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"key":"2021090119420736800_keaa905-B3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11926-007-0006-1","article-title":"The role of preventive cardiology in systemic lupus erythematosus","volume":"9","author":"Elliott","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"2021090119420736800_keaa905-B4","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N Engl J Med"},{"key":"2021090119420736800_keaa905-B5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D","article-title":"Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus","volume":"42","author":"Manzi","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2021090119420736800_keaa905-B6","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/art.22265","article-title":"Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus","volume":"54","author":"Farzaneh-Far","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2021090119420736800_keaa905-B7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/art.23196","article-title":"Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus","volume":"58","author":"Thompson","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2021090119420736800_keaa905-B8","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.amjcard.2013.05.040","article-title":"Relation of carotid intima-media thickness and plaque with incident cardiovascular events in women with systemic lupus erythematosus","volume":"112","author":"Kao","year":"2013","journal-title":"Am J Cardiol"},{"key":"2021090119420736800_keaa905-B9","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0002-9149(97)00701-7","article-title":"Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound","volume":"80","author":"Khoury","year":"1997","journal-title":"Am J Cardiol"},{"key":"2021090119420736800_keaa905-B10","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.autrev.2017.01.009","article-title":"Subclinical atherosclerosis in systemic lupus erythematosus: comparable risk with diabetes mellitus and rheumatoid arthritis","volume":"16","author":"Tektonidou","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2021090119420736800_keaa905-B11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/AC.70.2.3073508","article-title":"Systemic lupus erythematosus: the influence of disease-related and classical risk factors on intima media thickness and prevalence of atherosclerotic plaques\u2013a preliminary report. Beneficial effect of immunosuppressive treatment on carotid intima media thickness","volume":"70","author":"Kisiel","year":"2015","journal-title":"Acta Cardiol"},{"key":"2021090119420736800_keaa905-B12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jaut.2018.05.002","article-title":"B-cell activating factor and related genetic variants in lupus related atherosclerosis","volume":"92","author":"Theodorou","year":"2018","journal-title":"J Autoimmun"},{"key":"2021090119420736800_keaa905-B13","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1161\/STROKEAHA.107.487264","article-title":"Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromso Study","volume":"38","author":"Johnsen","year":"2007","journal-title":"Stroke"},{"key":"2021090119420736800_keaa905-B14","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1161\/01.STR.0000042207.16156.B9","article-title":"Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy","volume":"33","author":"Spence","year":"2002","journal-title":"Stroke"},{"key":"2021090119420736800_keaa905-B15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11886-009-0004-1","article-title":"Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease","volume":"11","author":"Johnsen","year":"2009","journal-title":"Curr Cardiol Rep"},{"key":"2021090119420736800_keaa905-B16","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2021090119420736800_keaa905-B17","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/rheumatology\/keh624","article-title":"BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus","volume":"44","author":"Isenberg","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"2021090119420736800_keaa905-B18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/rheumatology\/ken397","article-title":"Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus","volume":"48","author":"Batuca","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"2021090119420736800_keaa905-B19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/art.27286","article-title":"Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus","volume":"62","author":"O\u2019Neill","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2021090119420736800_keaa905-B20","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1002\/art.27546","article-title":"Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis","volume":"62","author":"Vuilleumier","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2021090119420736800_keaa905-B21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13075-015-0539-z","article-title":"IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study","volume":"17","author":"Croca","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2021090119420736800_keaa905-B22","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/rheumatology\/keg248","article-title":"Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome","volume":"42","author":"Delgado Alves","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"2021090119420736800_keaa905-B23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.STR.30.4.841","article-title":"Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study","volume":"30","author":"Ebrahim","year":"1999","journal-title":"Stroke"},{"key":"2021090119420736800_keaa905-B24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000073602","article-title":"Cardiovascular risk assessment using ultrasound: the value of arterial wall changes including the presence, severity and character of plaques","volume":"32","author":"Griffin","year":"2002","journal-title":"Pathophysiol Haemost Thromb"},{"key":"2021090119420736800_keaa905-B25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.autrev.2015.10.002","article-title":"Subclinical atherosclerosis in patients with systemic lupus erythematosus: a systemic review and meta-analysis","volume":"15","author":"Wu","year":"2016","journal-title":"Autoimmun Rev"},{"key":"2021090119420736800_keaa905-B26","doi-asserted-by":"crossref","first-page":"e0174572","DOI":"10.1371\/journal.pone.0174572","article-title":"Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: case control study of 281 SLE patients and 281 individually matched population controls","volume":"12","author":"Gustafsson","year":"2017","journal-title":"PLoS One"},{"key":"2021090119420736800_keaa905-B27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/eurheartj\/ehq521","article-title":"Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability","volume":"32","author":"Montecucco","year":"2011","journal-title":"Eur Heart J"},{"key":"2021090119420736800_keaa905-B28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.atherosclerosis.2016.10.045","article-title":"Determinants of carotid plaque burden","volume":"255","author":"Spence","year":"2016","journal-title":"Atherosclerosis"},{"key":"2021090119420736800_keaa905-B29","doi-asserted-by":"crossref","first-page":"513","DOI":"10.5114\/aoms.2016.59924","article-title":"Adding carotid total plaque area to the Framingham risk score improves cardiovascular risk classification","volume":"3","author":"Perez","year":"2016","journal-title":"Arch Med Sci"},{"key":"2021090119420736800_keaa905-B30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/01.STR.0000116876.96334.82","article-title":"Higher levels of interleukin-6 are associated with lower echogenicity of carotid artery plaques","volume":"35","author":"Yamagami","year":"2004","journal-title":"Stroke"},{"key":"2021090119420736800_keaa905-B31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1159\/000207443","article-title":"The association between inflammatory markers and carotid atherosclerosis is sex dependent: the Troms\u00f8 Study","volume":"27","author":"Halvorsen","year":"2009","journal-title":"Cerebrovasc Dis"},{"key":"2021090119420736800_keaa905-B32","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1253\/circj.67.1013","article-title":"Ultrasonic tissue characterization of the atherosclerotic carotid artery: histological correlates or carotid integrated backscatter","volume":"67","author":"Waki","year":"2003","journal-title":"Circ J"},{"key":"2021090119420736800_keaa905-B33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ejvs.2015.11.013","article-title":"Plaque echolucency and the risk of ischaemic stroke in patients with asymptomatic carotid stenosis within the first Asymptomatic Carotid Surgery Trial (ACST-1)","volume":"51","author":"Huibers","year":"2016","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2021090119420736800_keaa905-B34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/hc2601.091704","article-title":"Ultrasonic echolucent carotid plaques predict future strokes","volume":"104","author":"Gr\u00f8nholdt","year":"2001","journal-title":"Circulation"},{"key":"2021090119420736800_keaa905-B35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1253\/circj.CJ-13-0783","article-title":"Echolucency of carotid plaque is useful for assessment of residual cardiovascular risk in patients with chronic coronary artery disease who achieve LDL-C goals on statin therapy","volume":"78","author":"Uematsu","year":"2014","journal-title":"Circ J"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaa905\/35466692\/keaa905.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/9\/4185\/40214907\/keaa905.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/9\/4185\/40214907\/keaa905.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:43:04Z","timestamp":1630525384000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/9\/4185\/6065956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,1,6]]},"published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa905","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9,1]]},"published":{"date-parts":[[2021,1,6]]}}}